Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT04939012
- Status
- Recruiting
Conditions
- Contraception
- Pregnancy Related
- Substance Use Disorders
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MyPath Intervention — BEHAVIORALMyPath is a novel patient-centered, reproductive planning decision support tool developed by the research team used to facilitate postpartum contraceptive decision-making among women with SUDs. Designed to facilitate high-quality decisions regarding pregnancy and contraception, MyPath helps women a) review their thoughts about pregnancy and children, b) learn about fertility and preconception health and c) prioritize their preferences for various contraceptive method characteristics (e.g. effectiveness, side effects). As such, MyPath uses a patient-centered approach to help women frame their contraceptive decisions in the context of their goals and health and is a critical first step towards addressing reproductive health inequities among women with SUDs.
- Usual care — BEHAVIORALStandard of Care
Study Details
This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.
Key Dates
- Start date
- Oct 11, 2022
- Status verified
- Feb 2026
- Primary completion
- Mar 1, 2027
- Completion
- Mar 1, 2027
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: MyPath InterventionAt the first visit participants randomized to this arm receive MyPath contraceptive decision tool.
- Active Comparator: Standard of CareAt the first visit participants randomized to this arm receive standard of care contraceptive counseling.
Primary Outcome Measure
Contraceptive method continuation [ Time Frame: Delivery (Immediate Post-delivery Inpatient Visit) to 18 months post delivery ]
Central Contacts
- Elizabeth Krans, MD(412) 641-3532
- Samantha Mayo, BA(412) 641-2248
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Magee Womens Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 |
Find similar trials in Pittsburgh, PA
By research site
Related Studies
- Early Antenatal Support for Iron Deficiency AnemiaPHASE4 · Recruiting · Thomas Jefferson University · Philadelphia, Pennsylvania
- MIO-CPP to Improve the Well-being, Permanency, and Safety Outcomes for Young Children at Risk of or in Out-of-home Placement in Philadelphia and Bucks Counties, and Affected by Maternal Substance UseEnrolling By Invitation · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Evaluation of the Efficacy, Safety, and Tolerability of LevoCeptPHASE3 · Not Yet Recruiting · Sebela Women's Health Inc. · Berkeley, California
- Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and BreastfeedingRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania